Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

The Ukrainian Diabetic Federation (UDF) is launching a YouTube channel and Diabetic School for journalists and bloggers to ...

Gestational diabetes in India affects 10-14% of pregnant women, higher than in western countries, with genetic and ...

Alkem Laboratories on Wednesday said it has launched a generic medication for the treatment of type-2 diabetes mellitus, ...

High-intensity interval training was associated with improved glycemic control and cardiometabolic outcomes among patients with type 2 diabetes.

The researchers highlighted the importance of incorporating the Trabecular Bone Score alongside aBMD assessments for a more ...

The prevalence of LVH increased progressively across METS-VF quartiles, ranging from 7.9% to 31%. Higher METS-VF levels were ...

Glenmark Pharmaceuticals on Wednesday said it has launched a medication for glycemic control and weight-loss for diabetes ...

Gaps in the Greek data registry and problems in patient access to healthcare and disease management persist, reports the study on diabetes care in Greece.

Vagal Neuromodulation Provides Route to Treat Type 2 Diabetes and HypoglycemiaIRVINE, Calif., March 10, 2025 (GLOBE NEWSWIRE) ...

Glenmark launches Empagliflozin and combinations in India under Glempa brand, aiming to improve glycemic control and reduce ...

Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India ...